Menten AI
Menten AI is a drug discovery company in San Francisco, United States, founded in 2020. It has raised $3.8M across 3 rounds, most recently a $3.6M Seed in June 2020.
Menten AI designs peptide and protein therapeutics using quantum…
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- menten.ai
- Total Funding
- $3.8M
- Last Round
- $3.6M SeedJun 2020
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.
Summary
It lists 1–10 employees. It has raised $3.8M in total across 3 rounds, most recently a $3.6M Seed round in Jun 2020. Investors include Uncork Capital, Khosla Ventures and Y Combinator.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2020
Sign up to see all 3 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/menten-ai"><img src="https://indexed.vc/api/badge/company/menten-ai" alt="Menten AI on Indexed.vc" width="260" height="76" /></a>